ClinicalTrials.gg
Active, not recruitingNCT07353008Updated Jan 23, 2026

Effect of Different Chelation Protocols on the Healing of Periapical Lesions in Teeth With Chronic Apical Periodontitis

An interventional study of Final irrigation with 2.5% NaOCl and 17% EDTA and Final irrigation with 2.5% NaOCl and 9% HEBP in Chronic Apical Periodontitis, sponsored by Mustafa Kemal University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-23.

Sponsored by Mustafa Kemal University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Periapical Periodontitis with a site in Turkey — 13 open to participants now, 20 under way, none of them phase 3. Periapical Periodontitis · Turkey.

Planned enrollment
40th of 75
63 · median 66
Started
2025
with 14 others
No phase
73 of 81
11 open now
Primary completion
2027-04
later than 16 of 19 live
Registered
58th of 81
by date

Among the 81 studies in Periapical Periodontitis with a site in Turkey, this one is the 40th largest by planned enrollment of the 75 interventional ones that give a count, is one of 15 that started in 2025, is one of 73 with no phase, reaches primary completion later than 16 of the 19 other live ones, and was the 58th registered.

Periapical Periodontitis

281 studies on the registry are indexed under Periapical Periodontitis; 79 are open to participants now.

Browse Periapical Periodontitis studies →

Open to participants now

13 of the 81 studies in Periapical Periodontitis with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 43 Periapical Periodontitis studies recruiting now, 17 (40%) set no upper age limit and 25 (58%) stop at 75 or younger; 5 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Periapical Periodontitis with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effects of different irrigation protocols using ethylenediaminetetraacetic acid (EDTA) and etidronic acid (HEBP) on periapical lesion healing and postoperative pain in single-rooted, single-canal mandibular anterior and premolar teeth diagnosed with chronic apical periodontitis.

Read the detailed description

Materials and Methods Study Design This study was designed as a randomized clinical trial with three parallel experimental arms and included data obtained from a total of 63 patients.

Randomization and Blinding

Patients were randomly allocated to one of the following three groups:

Irrigation with 2.5% sodium hypochlorite (NaOCl) during canal preparation and 17% ethylenediaminetetraacetic acid (EDTA) as the final irrigant; Irrigation with 2.5% NaOCl during canal preparation and a combination of 2.5% NaOCl and 9% etidronic acid (HEBP) as the final irrigant; Irrigation with a mixture of 2.5% NaOCl and 9% HEBP throughout the entire irrigation protocol.

Randomization was performed using an online randomization tool (www.randomizer.org). Block randomization with a block size of four was applied to ensure an equal 1:1 allocation among the study groups. All endodontic procedures were performed by a single experienced operator. Due to the inherent differences between the irrigation protocols, blinding of the patients, the operator, and the radiographic evaluator was not feasible.

Clinical Intervention Inferior alveolar nerve block anesthesia was administered using 4% articaine with 1:100,000 epinephrine (Ultracain DS; Sanofi-Aventis, Germany). Following rubber dam isolation, all carious tissue was removed non-selectively under water cooling using a sterile high-speed diamond bur, and cavity preparation was completed with a sterile round bur mounted on a low-speed handpiece.

Subsequently, root canal treatment was performed according to the assigned group protocol, consisting of either 2.5% NaOCl and 17% EDTA as the final irrigation regimen, 2.5% NaOCl and 9% HEBP as the final irrigation regimen, or 2.5% NaOCl and 9% HEBP used both during canal preparation and as the final irrigation solution.

Irrigation Procedures Group I: Final Irrigation with 2.5% NaOCl and 17% EDTA After access cavity preparation, the working length (WL) was determined using an electronic apex locator (Root ZX; Morita, Tokyo, Japan) and confirmed radiographically. Following glide path preparation, the root canals were shaped to the working length using Reciproc files (VDW, Munich, Germany) according to the manufacturer's instructions, employing a crown-down preparation technique. During canal instrumentation, irrigation was performed with a total volume of 20 mL of 2.5% NaOCl. Upon completion of canal preparation, irrigation was carried out sequentially with 10 mL of distilled water, 3 mL of 17% EDTA, 10 mL of distilled water, and a final rinse with 2 mL of 2.5% NaOCl.

Group II: Final Irrigation with 2.5% NaOCl and 9% HEBP After access cavity preparation, the working length was determined using an electronic apex locator and confirmed radiographically. Following glide path preparation, root canal shaping was performed to the working length using Reciproc files in accordance with the manufacturer's recommendations and a crown-down technique. During canal preparation, irrigation was performed using a total of 20 mL of 2.5% NaOCl. After instrumentation, the canals were irrigated with 10 mL of distilled water, followed by final irrigation with 5 mL of a solution containing 2.5% NaOCl and 9% HEBP.

Group III: Irrigation with 2.5% NaOCl-9% HEBP During Both Preparation and Final Irrigation After access cavity preparation, the working length was established using an electronic apex locator and confirmed radiographically. Glide path preparation was followed by canal shaping to the working length using Reciproc files with a crown-down technique. Throughout both canal preparation and final irrigation, a total of 25 mL of a solution containing 2.5% NaOCl and 9% HEBP was used for irrigation.

Root Canal Obturation Following completion of the irrigation procedures, the root canals were dried with sterile paper points and obturated using gutta-percha cones in combination with a calcium silicate-based sealer, employing the cold lateral condensation technique. A postoperative periapical radiograph was obtained after obturation. Teeth exhibiting overfilling beyond the radiographic apex or obturation terminating more than 2 mm short of the apex were excluded from the study.

Final Restoration A 3-mm-thick layer of flowable composite resin was placed in the pulp chamber. The remaining coronal restoration was completed using composite resin with an incremental layering technique. After removal of the rubber dam, occlusal adjustments were performed, and the restoration was finished and polished during the same appointment. Immediate postoperative periapical radiographs were then obtained.

Patients were instructed to return for follow-up examinations at 3, 6, and 12 months, or earlier if any symptoms occurred.

Postoperative Pain Management For postoperative pain control, patients were prescribed 400 mg ibuprofen tablets to be taken as needed. Patients were instructed to record the frequency of analgesic intake in writing. In cases of severe postoperative pain not relieved by analgesics, patients were advised to contact the operator immediately.

Evaluation Criteria and Follow-up Examinations Clinical and Radiographic Follow-up Patients were recalled at 3, 6, and 12 months for clinical and radiographic examinations. At each follow-up visit, the clinical and radiographic outcomes of the treated teeth were recorded.

Clinical Success Criteria

Clinical success was defined as:

Absence of spontaneous pain or discomfort, except during the initial postoperative days; Absence of tooth mobility greater than Grade I; Normal periradicular soft tissues without swelling or sinus tract formation; Negative responses to axial palpation and percussion tests. Radiographic Success Criteria

Radiographic success was defined as:

No increase in the Periapical Index (PAI) score at follow-up; Absence of extra-radicular or intra-radicular pathology; No evidence of internal or external root resorption. Additional Assessments The integrity of the coronal restoration was evaluated at each follow-up visit, and any need for replacement or re-restoration was recorded. Additionally, the presence of clinical symptoms, including percussion sensitivity, sinus tract formation, and extraoral abscess, was assessed at all follow-up appointments.

03

Conditions studied

  • Chronic Apical Periodontitis

Keywords

  • Etidronic acid (HEBP)
  • Ethylenediaminetetraacetic acid (EDTA)
  • Sequential chelation
  • Consecutive chelation
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy patients of both sexes aged 18-60 years, with no systemic diseases, will be screened for inclusion in the study. Strict eligibility criteria will be applied.

Eligible patients will present with restorable mandibular single-rooted premolar and anterior teeth, a healthy periodontal status (periodontal pocket depth ≤3 mm), and a clinical diagnosis of chronic apical periodontitis. The diagnosis of chronic apical periodontitis will be based on the absence of clinical symptoms, the presence of pulpal necrosis, negative responses to electric pulp testing and cold testing, and the detection of a radiolucent area in the periapical region on radiographic examination. In addition, included teeth must exhibit a periapical lesion with a Periapical Index (PAI) score of 2 or higher.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases (such as diabetes mellitus, hypertension, chronic liver disease, or coagulation disorders), those with bone metabolism disorders and/or those using medications that affect bone metabolism (including and bisphosphonates), and pregnant patients will be excluded from the study.

In addition, teeth presenting with periodontal pocket depths greater than 3 mm, internal or external root resorption, vertical or horizontal root fractures, a history of previous root canal treatment, the presence of a sinus tract, or intraoral or extraoral abscess associated with the involved tooth, as well as teeth deemed non-restorable, will not be included in the study.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
63 participants (estimated)

Study arms

  • Active comparator
    Group I: Final irrigation with 2.5% NaOCl and 17% EDTA

    After preparation of the access cavity the working length (WL) will be determined using an electronic apex locator (Root ZX \[Morita, Tokyo, Japan\]) and confirmed radiographically. Following glide path preparation, the root canals will be shaped to the working length using a Resiproc files (VDW, Munich, Germany) in accordance with the manufacturer's instructions, employing the crown-down preparation technique. During canal preparation, irrigation will be performed with a total of 20 mL of 2.5% NaOCl. After completion of preparation, irrigation will be carried out with 10 mL of distilled water, followed by sequential irrigation with 3 mL of 17% EDTA, 10 mL of distilled water, and 2 mL of 2.5% NaOCl.

    Procedure: Final irrigation with 2.5% NaOCl and 17% EDTA

  • Experimental
    Group II: Final irrigation with 2.5% NaOCl and 9% HEBP

    After preparation of the access cavity, the working length (WL) will be determined using an electronic apex locator (Root ZX \[Morita, Tokyo, Japan\]) and confirmed radiographically. Following glide path preparation, the root canals will be shaped to the working length using a Resiproc files (VDW, Munich, Germany) in accordance with the manufacturer's instructions, employing the crown-down preparation technique. During canal preparation, irrigation will be performed with a total of 20 mL of 2.5% NaOCl. After completion of preparation, irrigation will be carried out with 10 mL of distilled water, followed by final irrigation with 5 mL of 2.5% NaOCl-9% HEBP.

    Procedure: Final irrigation with 2.5% NaOCl and 9% HEBP

  • Experimental
    Group III: Irrigation with 2.5% NaOCl-9% HEBP during both preparation and final irrigation

    After preparation of the access cavity, the working length (WL) will be determined using an electronic apex locator (Root ZX \[Morita, Tokyo, Japan\]) and confirmed radiographically. Following glide path preparation, the root canals will be shaped to the working length using a Resiproc files (VDW, Munich, Germany) in accordance with the manufacturer's instructions, employing the crown-down preparation technique. During both canal preparation and final irrigation, a total of 25 mL of 2.5% NaOCl-9% HEBP will be used for irrigation.

    Procedure: Irrigation with 2.5% NaOCl-9% HEBP during both preparation and final irrigation

Interventions

  • ProcedureFinal irrigation with 2.5% NaOCl and 17% EDTA

    During canal preparation, irrigation will be performed with a total of 20 mL of 2.5% NaOCl. After completion of preparation, irrigation will be carried out with 10 mL of distilled water, followed by sequential irrigation with 3 mL of 17% EDTA, 10 mL of distilled water, and 2 mL of 2.5% NaOCl.

  • ProcedureFinal irrigation with 2.5% NaOCl and 9% HEBP

    During canal preparation, irrigation will be performed with a total of 20 mL of 2.5% NaOCl. After completion of preparation, irrigation will be carried out with 10 mL of distilled water, followed by final irrigation with 5 mL of 2.5% NaOCl-9% HEBP.

  • ProcedureIrrigation with 2.5% NaOCl-9% HEBP during both preparation and final irrigation

    During both canal preparation and final irrigation, a total of 25 mL of 2.5% NaOCl-9% HEBP will be used for irrigation.

06

What researchers measure

Primary outcomes

  1. Periapical Lesion Healing

    Radiographic periapical status assessed using the Periapical Index (PAI) according to Ørstavik et al., with scores ranging from 1 (normal periapical structures) to 5 (severe apical periodontitis), based on the degree of periapical radiolucency. The primary outcome will be periapical lesion healing, evaluated by changes in periapical index (PAI) scores on periapical radiographs taken before treatment and at the 12-month follow-up.

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Publications

  • Campello AF, Rodrigues RCV, Alves FRF, Miranda KR, Brum SC, Mdala I, Siqueira JF Jr, Rocas IN. Enhancing the Intracanal Antibacterial Effects of Sodium Hypochlorite with Etidronic Acid or Citric Acid. J Endod. 2022 Sep;48(9):1161-1168. doi: 10.1016/j.joen.2022.06.006. Epub 2022 Jun 22. PubMed 35750221 ↗
  • Hazar E, Hazar A. Effects of phytic acid and etidronic acid using continuous and sequential chelation on the removal of smear layer, dentin microhardness, and push-out bond strength of calcium silicate-based cement. BMC Oral Health. 2025 Apr 24;25(1):633. doi: 10.1186/s12903-025-06010-5. PubMed 40275217 ↗
  • Tartari T, Wilchenski BS, de Souza Lima LA, Vivan RR, Ballal V, Duarte MAH. The use of sodium hypochlorite mixed with etidronic acid during canal preparation increases debris extrusion. Aust Endod J. 2023 Dec;49(3):584-591. doi: 10.1111/aej.12788. Epub 2023 Aug 11. PubMed 37571801 ↗
  • Razumova S, Brago A, Kryuchkova A, Troitskiy V, Bragunova R, Barakat H. Evaluation of the efficiency of smear layer removal during endodontic treatment using scanning electron microscopy: an in vitro study. BMC Oral Health. 2025 Jan 28;25(1):151. doi: 10.1186/s12903-025-05510-8. PubMed 39875846 ↗
  • Pandya DS, Kritika S, Sanjeev K, Mahalaxmi S, Neelakantan P. Endotoxin Levels after Calcium Hydroxide Placement in Root Canals Irrigated with Continuous or Sequential Chelation in Previously Treated Teeth with Symptomatic Apical Periodontitis: A Randomized Controlled Clinical Trial. J Endod. 2025 Nov;51(11):1519-1525. doi: 10.1016/j.joen.2025.08.004. Epub 2025 Aug 18. PubMed 40835176 ↗

Individual participant data

Plan to share: No — No plan to share IPD due to confidentiality and privacy considerations.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Apr 2027, 16 months after the start.

Of 172 non-industry interventional studies with no phase under Periapical Periodontitis, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 19. This study's planned 16 months is above that.

Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 6 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Jan 20, 2026
StartActual
Dec 1, 2025
Primary completionEst.
Apr 2027
CompletionEst.
Aug 2027
Last update
Jan 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07353008
Lead sponsor
Mustafa Kemal University
Responsible party
Merve Sari (Assistant Professor, Mustafa Kemal University) — Principal investigator
First posted
Jan 20, 2026
Start date
Dec 1, 2025
Primary completion
Apr 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Jan 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion